Skip to main content
. 2017 Jun 29;2017(6):CD011412. doi: 10.1002/14651858.CD011412.pub2
Methods Randomised, parallel‐group trial conducted in a rural district of West Bengal, India
2 treatment arms: PHB and PHT
Participants Children from a rural district of a developing country (India) who had experienced 2 or more unprovoked seizures within the 12 months preceding the trial and had been untreated in the 3 months preceding the trial
Number randomised: PHB = 47 ; PHT = 47
47 boys (50%)
60 children had partial epilepsy (64%)
Mean age (range): 11 (2‐18) years
Interventions Monotherapy with PHB or PHT
Maintenance doses: PHT = 5 mg/kg/d, PHB = 3 mg/kg/d. Daily dose achieved not stated
Range of follow‐up: 0.5‐13 months
Outcomes Time to first seizure
Proportion seizure‐free in each trial quarter
Proportion of adverse events including behavioural side effects
Notes IPD provided for remission and seizure outcomes of this review by the trial author. Withdrawal information not available
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk First 10 participants randomised from a pre‐prepared balanced random number list, following participants randomised by minimisation with stratification by age group and presence of cerebral impairment
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel (performance bias) All outcomes High risk Participants, parents and treating physicians unblinded for “practical and ethical reasons.” Withdrawal information from treatments not available, however lack of blinding may have influenced withdrawal rates
Blinding of outcome assessment (detection bias) All outcomes Low risk Outcome assessors single‐blinded
Incomplete outcome data (attrition bias) All outcomes Low risk Attrition rates reported, ITT approach, all randomised participants analysed from IPD provided (see footnote 2)
Selective reporting (reporting bias) Low risk All outcomes reported or calculated with IPD provided (see footnote 2)
Other bias Low risk None identified